Category Archives : Strategic GPS


Experiencing facts with a fresh perspective — and the results you can achieve

  Here is an instance from my he bio-pharma work when N-of-8 listening and research produced significant results. A mid-sized biopharmaceutical company with a promising pipeline of new therapies exemplified this.  Back in 2003, the drugs in research seemed to be in disparate categories:  Crohn’s disease, MS, and Alzheimer’s disease.  Then during N-of-8 groups, we asked a naïve question, “Is there any connection between them?”  This childlike curiosity led us on an intriguing pursuit of a neuro-gastro commonality and we found an emerging appreciation of the brain-gut connection. By looking at the company’s existing research with a fresh perspective, we […]


The corporate and scholarly research worlds could learn much from each other: “An Academia-Big Pharma Truce”

from Dr. Marc Siegel, a professor of medicine and medical director of Doctor Radio at New York University’s Langone Medical Center, writing in the Wall Street Journal today.   Most Americans are unaware how many great scientists, trained in academia, now work in private pharmaceutical laboratories. A 2010 paper in the peer-reviewed journal Nature Reviews Drug Discovery confirmed that the vast majority of pharmaceuticals now in use were discovered in drug-company labs, where a process known as high-throughput screening allows computer analysis of thousands of compounds to determine those with the best activity against certain diseases. Big Pharma pioneered this […]


Consider all the other Marketing P’s — there is more than “product” in life cycle planning

Remember to look at more than just the “product” in life cycle planning. Consider all the other Marketing P’s: – Place (distribution) – Price (contracts, incentives) – Promotion (unique channels) – Packaging (novel, convenient) – Put-ups (sizes, kits, bundles) – Personal support (services offerings) – Professional development (education, training, certification)


Why McKesson acquired CoverMyMeds: “untapped treasure trove”

Drug distributor and health care technology firm, McKesson, recently announced it would acquire CoverMyMeds for $1.1 billion. This is a company that automates prior authorizations online through electronic health record systems but this is only one way the company is developing new analytic tools to help solve problems for specialists. McKesson says it’s also creating a new analytics tool for oncologists using advanced algorithms and natural language processing technology to read and re-format previously unstructured information. This helps healthcare companies that are collecting more data on patients but struggling to realize the full value of this data because much of […]


“Four Paths to Business Model Innovation” from HBR

I enjoy reading about business models for innovation and how to improve the discipline of decision making so that’s why the article, “Four Paths to Business Model Innovation”, in recent Harvard Business Review caught my eye. In this article, Karan Girotra and Serguei Netessine write about the secrets to success that lie in what decisions to make when and why. Drawing on the idea that any business model is essentially a set of key decisions that collectively determine how a business can earn its revenues, incur its costs and manage its risk, the author’s view innovations to the model as […]


Looking back on 2016   Recently updated !

As I look back on 2016 I’ve realized I had a chance to apply almost all the brand innovation tools I’ve developed over the years. I was able to apply them in a variety of market, client, and brand lifecycle situations. A2U – I conducted more interviews, dyads, and focus groups than in the past several years. The findings from these awareness,, attitude and usage interviews were used to develop key findings, implications, and actions for a number of clients. StrategicGPS – the mapping of where we are to where we want to be proved valuable for many brand team […]


“A new breed of analytics for VoC data is transforming not only the amount of customer insight that can be made available, but also the speed at which it is delivered.”

Usually we keep up with our industry trends and news by reading from the more common business magazines, Wall Street Journal, Fast Company, PharmaVoice etc… But every now and then an article pops up from an unconventional source that is worth a read. This article on the science and stats around ‘voice of the customer research’ was one such article. I wanted to pass it along to you as a reminder on the value of customer feedback. Enjoy the read! http://data-informed.com/get-most-from-your-voice-of-customer-data/


How to add StrengthFinder attributes to brand personality workshops

In facilitating workshops on brand personality, we often ask participants to “ladder up” to emotional attributes and core values. Similarly, in StrategicGPS workshops, we must articulate a vision of “where we want to be” to better serve the patients, HCPs, and other stakeholders. But often the ideas are limited by the group using the same strato-words (like “confidence” or “control”) – a factor of limited time and reliance on familiarity. One technique I’ve used for new descriptions is the attribute list in StrengthFinders 2.0, the longstanding business bestseller. Create a card deck of these attributes The Facilitator can prompt classic […]


People talking to people: It’s still how to change the world’s standards of practice

In my pharma client workshops, we are often focused on how to change clinical practice in a specific disease class. It often starts with a basic question of how to communicate new information, updated studies, or evidence-based guidelines. Some innovations spread fast. How do you speed the ones that don’t? Here is a very compelling story from Atul Gawande on how practice changed in a very personal way:   In 1968, The Lancet published the results of a modest trial of what is now regarded as among the most important medical advances of the twentieth century. It wasn’t a new […]


The American Health Care Paradox: Is spending more getting us less?

Discouragingly, many health care innovations in which Americans have placed so much stock have largely failed to deliver the desired outcomes or value. I had the opportunity to serve on a panel discussion about the future of home care with Lauren A. Taylor. Lauren has a master’s degree from the Yale School of Public Health and is now a doctoral student of health policy and management at Harvard Business School. “When we look to the front lines of health care and of social service delivery, however, we found that those who interact most closely with patients are recognizing the intersection […]